{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:26:26Z","timestamp":1793107586415,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ejogrb.2024.12.027","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:08:32Z","timestamp":1734595712000},"page":"292-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancer"],"prefix":"10.1016","volume":"305","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-4414","authenticated-orcid":false,"given":"Alistair","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxani","family":"Dampali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bertoni Sclavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib R.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anestis","family":"Touloumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Devaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas J.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Attard Montalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.12.027_b0005","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0010","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2014.04.046","article-title":"The survival detriment of venous thromboembolism with epithelial ovarian cancer","volume":"134","author":"Gunderson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ijgc-2019-000980","article-title":"Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer","volume":"30","author":"Salinaro","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0025","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa012385","article-title":"Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer","volume":"346","author":"Bergqvist","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0030","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/AOG.0b013e31818b1486","article-title":"A protocol of dual prophylaxis for venous thromboembolism prevention in gynecologic cancer patients","volume":"112","author":"Einstein","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0035","unstructured":"National Institute for Health and Care Excellence (NICE). Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE Guideline [NG89] 2018. https:\/\/www.nice.org.uk\/guidance\/ng89 (accessed December 4, 2024)."},{"key":"10.1016\/j.ejogrb.2024.12.027_b0040","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2021.07.030","article-title":"Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy","volume":"163","author":"Basaran","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0045","unstructured":"World Health Organisation. International Statistical Classification of Diseases and Related Health Problems: tenth revision, 2nd ed. 2004. https:\/\/iris.who.int\/handle\/10665\/42980 (accessed December 4, 2024)."},{"key":"10.1016\/j.ejogrb.2024.12.027_b0050","series-title":"Sampling Techniques","author":"Cochran","year":"1977"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2023.06.577","article-title":"Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?","volume":"176","author":"Shafa","year":"2023","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0060","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0065","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous thromboembolism in patients with cancer \u2013 a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2374716","article-title":"Meta-analysis of VTE Risk: ovarian cancer patients by stage, histology, cytoreduction, and ascites at diagnosis","volume":"2020","author":"Weeks","year":"2020","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0075","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","article-title":"Cancer therapy\u2013associated thrombosis","volume":"41","author":"Grover","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0085","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2023-005166","article-title":"Incidence of venous thromboembolism in patients with ovarian cancer receiving neoadjuvant chemotherapy: systematic review and meta-analysis","author":"Black","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2015.07.005","article-title":"Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery","volume":"138","author":"Ataseven","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1634\/theoncologist.2015-0284","article-title":"Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients","volume":"21","author":"K\u00f6nigsbr\u00fcgge","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0100","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jogc.2021.05.010","article-title":"Venous thromboembolism in patients receiving neoadjuvant chemotherapy for advanced ovarian cancer and impact on survival","volume":"43","author":"Black","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0105","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1200\/JCO.2019.37.15_suppl.5508","article-title":"EWOC-1: A randomized trial to evaluate the feasibility of three different first-line chemotherapy regimens for vulnerable elderly women with ovarian cancer (OC): A GCIG-ENGOT-GINECO study","volume":"37","author":"Falandry","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/annonc\/mdl401","article-title":"Feasibility, toxicity and quality of life of first-line chemotherapy with platinum\/paclitaxel in elderly patients aged \u226570 years with advanced ovarian cancer\u2014a study by the AGO OVAR Germany","volume":"18","author":"Hilpert","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.amjsurg.2018.11.046","article-title":"Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery","volume":"218","author":"Carrier","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/tog.12849","article-title":"Thromboprophylaxis in gynaecology: a review of current evidence","volume":"25","author":"Nambiar","year":"2023","journal-title":"Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0130","article-title":"Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy","volume":"2020","author":"Rutjes","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0135","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2024.12.027_b0145","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS\u2013cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524007012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524007012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T15:33:30Z","timestamp":1737387210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524007012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":29,"alternative-id":["S0301211524007012"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.12.027","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for venous thromboembolism in patients undergoing neoadjuvant chemotherapy as treatment for ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}